Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 1647 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact1647 DOIs

Add abstracts to 678 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact678 DOIs

Deposit reference lists for 678 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact678 DOIs

DOIs for this ISSN

Showing the top 5 of 9451 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	The patient perspective in the era of personalized medicine:… (10.1002/cam4.3889)	Abstract ORCID	75.26	31
2	A mi<scp>RNA</scp>s panel promotes the proliferation and inv… (10.1002/cam4.760)	References ORCID	74.57	30
3	<i>β</i>‐caryophyllene and <i>β</i>‐caryophyllene oxide—natu… (10.1002/cam4.816)	ORCID	69.67	611
4	New prognostic factors and scoring system for patients with… (10.1002/cam4.292)	ORCID	64.41	376
5	<scp>PD</scp>‐1 as a potential target in cancer therapy (10.1002/cam4.106)	ORCID	62.90	327
6	The precision prevention and therapy of… (10.1002/cam4.1501)	ORCID	61.37	284
7	Nisin, an apoptogenic bacteriocin and food preservative, att… (10.1002/cam4.35)	ORCID	60.12	253
8	Ipilimumab and radiation therapy for melanoma brain metastas… (10.1002/cam4.140)	ORCID	59.60	241
9	Vessel co‐option in primary human tumors and metastases: an… (10.1002/cam4.105)	ORCID	59.51	239
10	Projections of cancer incidence and cancer‐related deaths in… (10.1002/cam4.767)	ORCID	59.04	229
11	Response rates and durability of chemotherapy among 62 patie… (10.1002/cam4.815)	ORCID	58.66	221
12	<scp>BAY</scp> 87‐2243, a highly potent and selective inhibi… (10.1002/cam4.112)	ORCID	58.16	211
13	Cancer survival disparities by health insurance status (10.1002/cam4.84)	ORCID	57.85	205
14	The role of laser interstitial thermal therapy in enhancing… (10.1002/cam4.266)	ORCID	57.36	196
15	Overexpression of Snail induces epithelial–mesenchymal trans… (10.1002/cam4.4)	ORCID	57.14	192
16	Cancer‐associated fibroblasts promote M2 polarization of mac… (10.1002/cam4.993)	ORCID	56.91	188
17	A novel plasma circular <scp>RNA</scp> circ<scp>FARSA</scp>… (10.1002/cam4.1514)	ORCID	56.44	180
18	MicroRNAs in glioblastoma multiforme pathogenesis and therap… (10.1002/cam4.775)	ORCID	55.50	165
19	U‐251 revisited: genetic drift and phenotypic consequences o… (10.1002/cam4.219)	ORCID	55.44	164
20	Role of DUSP1/MKP1 in tumorigenesis, tumor progression and t… (10.1002/cam4.772)	ORCID	54.76	154
21	CXCL9: evidence and contradictions for its role in tumor pro… (10.1002/cam4.934)	ORCID	54.47	150
22	Lean body mass as an independent determinant of dose‐limitin… (10.1002/cam4.621)	ORCID	54.33	148
23	Noninvasive detection of lung cancer using exhaled breath (10.1002/cam4.162)	ORCID	54.26	147
24	The scientific method: pillar and pitfall of cancer research (10.1002/cam4.248)	Abstract ORCID	53.96	11
25	Overexpression of the microRNA miR‐433 promotes resistance t… (10.1002/cam4.409)	ORCID	53.73	140
26	<i>Salmonella enterica</i>serovar Typhi and gallbladder canc… (10.1002/cam4.915)	ORCID	53.73	140
27	Global loss of a nuclear lamina component, lamin A/C, and <s… (10.1002/cam4.495)	ORCID	53.58	138
28	Systematic review of sleep disorders in cancer patients: can… (10.1002/cam4.356)	ORCID	53.26	134
29	The impact of early detection and intervention of breast can… (10.1002/cam4.691)	ORCID	53.26	134
30	Xanthine oxidoreductase in cancer: more than a differentiati… (10.1002/cam4.601)	ORCID	53.10	132
31	HuR‐regulated lnc<scp>RNA NEAT</scp>1 stability in tumorigen… (10.1002/cam4.710)	ORCID	53.10	132
32	Evaluation of a prognostic model for risk of relapse in stag… (10.1002/cam4.324)	ORCID	52.85	129
33	Targeting hyperactivation of the <scp>AKT</scp> survival pat… (10.1002/cam4.50)	ORCID	52.60	126
34	Urban–rural disparities in colorectal cancer screening: cros… (10.1002/cam4.40)	ORCID	52.34	123
35	LncRNA PVT1 regulates prostate cancer cell growth by inducin… (10.1002/cam4.900)	ORCID	52.16	121
36	Antiproliferative and metabolic effects of metformin in a pr… (10.1002/cam4.353)	ORCID	51.98	119
37	<scp>CTLA</scp>‐4 blockade with ipilimumab: biology, safety,… (10.1002/cam4.371)	ORCID	51.89	118
38	Strategies for discovery and validation of methylated and hy… (10.1002/cam4.22)	ORCID	51.80	117
39	The hedgehog pathway in triple‐negative breast cancer (10.1002/cam4.833)	ORCID	51.61	115
40	A retrospective analysis of the effect of intraoperative opi… (10.1002/cam4.236)	ORCID	51.52	114
41	Atypical teratoid rhabdoid tumor: improved long‐term surviva… (10.1002/cam4.161)	ORCID	51.42	113
42	Prognostic factors and sites of metastasis in unresectable l… (10.1002/cam4.459)	ORCID	51.42	113
43	Long noncoding <scp>RNA </scp><i><scp>HOTAIR</scp></i> is re… (10.1002/cam4.220)	ORCID	51.33	112
44	A systematic review of microRNA expression profiling studies… (10.1002/cam4.246)	ORCID	51.03	109
45	Sirolimus effects on cancer incidence after kidney transplan… (10.1002/cam4.487)	ORCID	50.94	108
46	<scp>CD</scp>47 is an adverse prognostic factor and a therap… (10.1002/cam4.478)	ORCID	50.73	106
47	The impact of genetic heterogeneity on biomarker development… (10.1002/cam4.293)	ORCID	50.63	105
48	A time and motion study of subcutaneous versus intravenous t… (10.1002/cam4.573)	ORCID	50.22	101
49	Systemic treatment of metastatic uveal melanoma: review of l… (10.1002/cam4.133)	ORCID	50.00	99
50	A role for G‐CSF and GM‐CSF in nonmyeloid cancers (10.1002/cam4.239)	ORCID	49.89	98